| Literature DB >> 34863202 |
Hongke Qu1,2,3, Chunmei Fan2, Mingjian Chen2, Xiangyan Zhang4, Qijia Yan2,5, Yumin Wang2,5, Shanshan Zhang5, Zhaojian Gong6, Lei Shi6, Xiayu Li3, Qianjin Liao1, Bo Xiang2, Ming Zhou2, Can Guo2, Guiyuan Li1,2, Zhaoyang Zeng1,2, Xu Wu7,8, Wei Xiong9,10.
Abstract
The cyclic signal amplification technology has been widely applied for the ultrasensitive detection of many important biomolecules, such as nucleic acids, proteins, enzymes, adenosine triphosphate (ATP), metal ions, exosome, etc. Due to their low content in the complex biological samples, traditional detection methods are insufficient to satisfy the requirements for monitoring those biomolecules. Therefore, effective and sensitive biosensors based on cyclic signal amplification technology are of great significance for the quick and simple diagnosis and treatment of diseases. Fluorescent biosensor based on cyclic signal amplification technology has become a research hotspot due to its simple operation, low cost, short time, high sensitivity and high specificity. This paper introduces several cyclic amplification methods, such as rolling circle amplification (RCA), strand displacement reactions (SDR) and enzyme-assisted amplification (EAA), and summarizes the research progress of using this technology in the detection of different biomolecules in recent years, in order to provide help for the research of more efficient and sensitive detection methods.Entities:
Keywords: Biomedical detection; Cyclic signal amplification; Fluorescence biosensor
Mesh:
Substances:
Year: 2021 PMID: 34863202 PMCID: PMC8645109 DOI: 10.1186/s12951-021-01149-z
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Cyclic signal amplification strategies for fluorescent biosensors
| Method | Characteristic | Advantages | Disadvantages | Real samples | References |
|---|---|---|---|---|---|
| RCA | Template, Primer, polymerization, amplification, release target | Good amplification effect, single reaction conditions, full use of reaction materials, | Long reaction times, requiring specific amplification template | Cells, serum, tissue, plasma, fecal, beer, drinking water | [ |
| SDR | Hybridization, strand displacement, release target | No enzyme or cofactor, relatively simple experimental conditions, less external interference conditions, economical and cost-effective | Multiple probes or auxiliary strands need to be designed | Cells, serum, urine, milk, river water | [ |
| EAA | Hybridization, digestion, release target | No complex instrument, the signal is effective, the reaction is relatively thorough, and the time is short | Harsh reaction conditions, high temperature requirements, high cost of enzymes | Cells, serum, milk, artificial urine, river water | [ |
Fig. 1A Schematic illustration of circDNA as a template for RCA [21]. B Schematic diagram of sensitive detection of miRNA based on RCA (Linear DNA as a template) combined with DNAzyme [22]
Fig. 2A The basic schematic diagram of enzyme-free strategy [29]. B Schematic of sensitive detection of HIV-1 DNA based on toehold-mediated SDR [30]
Fig. 3A Schematic of sensitivity detection of miRNA by DSN-assisted cyclic amplification technology based on G-triple structure [14]. B Schematic diagram of the detection of RNase H by the fluorescence sensor based on EAA [39]. C Schematic illustration of sensitive detection of bacterial pathogens using the allosteric probe-initiated catalysis and CRISPR-Cas13a (APC-CAS) system [40]
Fig. 4A Schematic of DSN-assisted analyte recovery combined with RCA for sensitive detection of circulating miRNA [43]. B Schematic of RCA combined with T7 Exo-assisted circulation for sensitive detection of miRNA let-7a [47]
Different fluorescent biosensors based on CSA for biomolecules detection
| Biomarker | Analyte | Method | Time | Linear range | LOD | Real samples | Refs. |
|---|---|---|---|---|---|---|---|
| DNA | DNA | EAA (Nicking enzyme) | 45 min | 0–102 fM | 50 fM | Human serum | [ |
| DNA | EAA (RNase H) | 1 h | 0–50 pM | 23 fM | – | [ | |
| DNA | SDR | 40 min | 0–3 pM | 0.58 pM | – | [ | |
| RNA | mRNA | EAA (DSN) | 2 h | 10–4–1 nM | 102 fM | Cell lysates | [ |
| miRNA | SDR | 2 h | 4 × 10–3–40 nM | 1.48 pM | Cell lysates | [ | |
| miRNA | RCA | 4.5 h | 6.4 7 × 104–102 nM | 6.4 pM | Cell lysates and fetal bovine serum | [ | |
| lncRNA | EAA (DSN and APE1) | 3 h | 10–7–102 nM | 8.1 × 10–2 fM | Cell lysates | [ | |
| circRNA | RCA | 3.5 h | 2 × 10–3–50 pM | 1.1fM | Cell lysates | [ | |
| circRNA | EAA (DSN) | 30 min | 10–2–1 pM | 10 fM | Cell lysates | [ | |
| Protein | CEA | EAA (T7 Exo) | 65 min | 5 × 10–5–50 ng mL−1 | 28.5 fg mL−1 | Human serum | [ |
| AVP | EAA (Nt.AIwI) | 30 min | 75–7 × 102 pM | 75 pM | Fetal bovine serum | [ | |
| Insulin | EAA (Exo III) | 40 min | 4.8 × 10–2–2.15 U ml−1 | 4.8 × 10–2 U ml−1 | Fetal bovine serum | [ | |
| PSA | EAA (DNAzyme) | 2 h | 1–100 pg mL−1 | 0.76 pg mL−1 | Human serum | [ | |
| Enzyme | Telomerase | EAA (APE1) | 3.5 h | 1–105 cells | Single cell | Cell lysates | [ |
| Telomerase | EAA (Nt.AlwI) | 4.5 h | 0–1.5 × 10–5 IU | 8.93 × 10–11 IU | Cell lysates | [ | |
| UDG | RCA | > 12 h | 5 × 10–4– 5 × 10–2 U mL−1 | 1.4 × 10–4 U mL−1 | – | [ | |
| UDG | SDR | 3 h | 2 × 10–4– 2 × 10–2 U mL−1 | 10–4 U mL−1 | – | [ | |
| DNA MTase | SDR | 4.5 h | 10–5–1 U mL−1 | 3.3 × 10–6 U mL−1 | Human serum | [ | |
| T4 PNK | EAA (Exo III) | 5.5 h | 5 × 10–3–2 × 10–1 U mL−1 | 3.3 × 10–4 U mL−1 | Cell lysates and human serum | [ | |
| Biological small molecules | ATP | SDR and EAA (Nb.BbvCI) | 2.5 h | 5– 2 × 102 nM | 2.2 nM | Human serum | [ |
| ATP | EAA (Exo III) | 4 h | 20–6 × 102 nM | 8.32 nM | – | [ | |
| ATP | RCA and EAA (Endo IV) | 2.5 h | 10–1–5 × 102 nM | 9 × 10–2 nM | Human serum | [ | |
| GSH | RCA | 3 h | 102–108 pM | 10 pM | Cell lysates | [ | |
| OTA | RCA | > 12 h | 5 × 10–2–102 ng mL−1 | 10–2 ng mL−1 | Beer samples | [ | |
| NF-kB | EAA (Exo III) | 1 h | 50–103 pM | 45.6 pM | Cell lysates | [ | |
| Adenosine | EAA (T7 Exo) | 1 h | 5 × 10−6–7 × 10−4 mol L−1 | 9.8 × 10−7 mol L−1 | Artificial urine | [ | |
| Metal ions | Hg | EAA (Exo III) | 1.5 h | 10–5–102 nM | 10 fM | River water | [ |
| Hg | SDR | 2 h | 10–2–10 nM | 7.9 pM | River water | [ | |
| Pb | SDR | 30 min | 10−6–1 mM | 0.3 nM | Cell lysates | [ | |
| Pb | RCA | 1.5 h | 1 –102 nM | 0.91 nM | Drinking water | [ | |
| Cd | SDR | 2 h | 10–8–102 mM | 5 pM | Human urine and river water | [ | |
| Na+ | SDR | 4 h | 10–1–12 mM | 14 µM | Cell lysates | [ | |
| Exosomes | Exosome | RCA and EAA (Nb.BbvCI) | 3 h | 103–105 particles μL−1 | 102 particles μL−1 | Cell lysates and human serum | [ |
| Exosome | RCA | 4.5 h | 102–106 particles μL−1 | 42.7 particles μL−1 | Plasma samples | [ | |
| Exosome | EAA (DNase I) | 40 min | 3 × 104–6 × 105 particles μL−1 | 2.1 × 104 particles μL−1 | Human serum | [ | |
| Pathogens | Fn.n | RCA | 7 h | 7 × 10–1 − 7 × 104 ng L−1 | 0.7 ng L−1 | Fecal specimens | [ |
| S.Typhimurium | SDR | 2 h | 10–5 × 105 cfu mL−1 | 8 cfu mL−1 | Milk sample | [ | |
| Chlamydia trachomatis | EAA (FEN1) | 30 min | 0–1 nM | 6.7 pM | Human serum | [ |
Fig. 5A Schematic of Nicking enzyme-assisted biperiodic amplification for DNA sensitivity detection [58]. B Schematic diagram of enzyme-free amplified DNA detection based on molecular beacon [60]
Fig. 6A Schematic diagram of sensitive detection of VEGF mRNA and live cell imaging based on DSN-assisted cycling [68]. B Schematic diagram of G-quadruple probe based on 2-aminopurine binding SDR for sensitive detection of miRNA-21 [72]. C Schematic diagram for sensitive detection of lncRNA based on DSN and APE1 enzyme mediated triple cycle amplification [78]. D Schematic diagram for sensitive detection of circRNA based on RCA [84]
Fig. 7Schematic diagram of CEA sensitive detection by T7 Exo-asssted circulation based on the adsorption quenching effect of GO [96]
Fig. 8A Schematic diagram of sensitive detection of telomerase by enzyme-assisted amplification binding RCA based on telomere triggering [110]. B Schematic diagram of sensitively detection of Uracil-DNA glycosylase by RCA [112]
Fig. 9A Schematic diagram of Toehold mediated SDR in combination with enzyme-assisted amplification for ATP sensitive detection [120]. B Schematic diagram of sensitive detection of GSH and tumor cell imaging using RCA technology based on MnO2 nanometer tablets [126]
Fig. 10A Schematic diagram of Exo III-assisted cycle for sensitively detecting Hg2+ [140]. B Schematic diagram of SDR for sensitively detecting intracellular Pb2+ [144]
Fig. 11Schematic illustration for the detection of exosomes based on the dual signal amplification by combining RCA and endonuclease-assisted amplification [156]
Fig. 12Schematic diagram of simultaneous detection of two different miRNA by T7 Exo assisted circulation fluorescence sensor [16]